{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T13:01:30Z","timestamp":1789909290710,"version":"4.0.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T00:00:00Z","timestamp":1763856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T00:00:00Z","timestamp":1763856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer J."],"DOI":"10.1038\/s41408-025-01416-4","type":"journal-article","created":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T00:42:31Z","timestamp":1763858551000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Impact of expanding allogeneic stem cell transplantation on survival in acute myeloid leukemia: a population-based study"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4253-2924","authenticated-orcid":false,"given":"Brittany","family":"Salter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0579-6709","authenticated-orcid":false,"given":"Alejandro","family":"Garcia-Horton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0430-3837","authenticated-orcid":false,"given":"Irwin","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Leber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylie","family":"Lepic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1584-1067","authenticated-orcid":false,"given":"Hira","family":"Mian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Gayowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory R.","family":"Pond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsien","family":"Seow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,23]]},"reference":[{"key":"1416_CR1","unstructured":"Government of Canada SC. Cancer incidence trends, by sex and cancer type [Internet]. 2022 [cited 2024 Nov 29]. Available from: https:\/\/www.150.statcan.gc.ca\/t1\/tbl1\/en\/tv.action?pid=1310084001."},{"key":"1416_CR2","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H D\u00f6hner","year":"2022","unstructured":"D\u00f6hner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140:1345\u201377.","journal-title":"Blood"},{"key":"1416_CR3","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1182\/blood-2015-07-604546","volume":"127","author":"JJ Cornelissen","year":"2016","unstructured":"Cornelissen JJ, Blaise D. Hematopoietic stem cell transplantation for patients with AML in first complete remission. Blood. 2016;127:62\u201370.","journal-title":"Blood"},{"key":"1416_CR4","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1200\/JCO.2012.46.8652","volume":"31","author":"J Koreth","year":"2013","unstructured":"Koreth J, Pidala J, Perez WS, Deeg HJ, Garcia-Manero G, Malcovati L, et al. Role of reduced-intensity conditioning allogeneic hematopoietic stem-cell transplantation in older patients with de novo myelodysplastic syndromes: an international collaborative decision analysis. J Clin Oncol J Am Soc Clin Oncol. 2013;31:2662\u201370.","journal-title":"J Clin Oncol J Am Soc Clin Oncol"},{"key":"1416_CR5","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1200\/JCO.2013.50.5768","volume":"32","author":"M Stelljes","year":"2014","unstructured":"Stelljes M, Krug U, Beelen DW, Braess J, Sauerland MC, Heinecke A, et al. Allogeneic transplantation versus chemotherapy as postremission therapy for acute myeloid leukemia: a prospective matched pairs analysis. J Clin Oncol J Am Soc Clin Oncol. 2014;32:288\u201396.","journal-title":"J Clin Oncol J Am Soc Clin Oncol"},{"key":"1416_CR6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.leukres.2019.03.004","volume":"80","author":"J Hilberink","year":"2019","unstructured":"Hilberink J, Hazenberg C, van den Berg E, Mulder A, Schuringa JJ, van der Helm L, et al. Not type of induction therapy but consolidation with allogeneic hematopoietic cell transplantation determines outcome in older AML patients: A single center experience of 355 consecutive patients. Leuk Res. 2019;80:33\u20139.","journal-title":"Leuk Res"},{"key":"1416_CR7","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1182\/blood.2022016916","volume":"141","author":"ML Sorror","year":"2023","unstructured":"Sorror ML, Gooley TA, Storer BE, Gerds AT, Sekeres MA, Medeiros BC, et al. An 8-year pragmatic observation evaluation of the benefits of allogeneic HCT in older and medically infirm patients with AML. Blood. 2023;141:295\u2013308.","journal-title":"Blood"},{"key":"1416_CR8","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1001\/jamaoncol.2022.7605","volume":"9","author":"M Bornh\u00e4user","year":"2023","unstructured":"Bornh\u00e4user M, Schliemann C, Schetelig J, R\u00f6llig C, Kramer M, Glass B, et al. Allogeneic Hematopoietic Cell Transplantation vs Standard Consolidation Chemotherapy in Patients With Intermediate-Risk Acute Myeloid Leukemia: A Randomized Clinical Trial. JAMA Oncol. 2023;9:519\u201326.","journal-title":"JAMA Oncol"},{"key":"1416_CR9","first-page":"68","volume":"110","author":"D Niederwieser","year":"2025","unstructured":"Niederwieser D, Hasenclever D, Berdel WE, Biemond BJ, Al-Ali H, Chalandon Y, et al. Hematopoietic cell transplantation for older acute myeloid leukemia patients in first complete remission: results of a randomized phase III study. Haematologica. 2025;110:68\u201377.","journal-title":"Haematologica"},{"key":"1416_CR10","unstructured":"Meyer CL, Keegan THM, Brunson A, Auletta JJ, Morton LM, Wun T, et al. Utilization of allogeneic hematopoietic stem cell transplantation among patients with newly diagnosed acute myeloid leukemia in California: a population-based linked dataset study. Haematologica. 2024;110:368\u221277."},{"key":"1416_CR11","doi-asserted-by":"publisher","first-page":"e039293","DOI":"10.1136\/bmjopen-2020-039293","volume":"10","author":"SA Hershenfeld","year":"2020","unstructured":"Hershenfeld SA, Matelski J, Ling V, Paterson M, Cheung M, Cram P. Utilisation and outcomes of allogeneic hematopoietic cell transplantation in Ontario, Canada, and New York State, USA: a population-based retrospective cohort study. BMJ Open. 2020;10:e039293.","journal-title":"BMJ Open"},{"key":"1416_CR12","doi-asserted-by":"publisher","first-page":"5198","DOI":"10.3390\/curroncol29080412","volume":"29","author":"O Morakinyo","year":"2022","unstructured":"Morakinyo O, Bucher O, Paulson K. Access to Hematopoietic Stem Cell Transplant in Canada for Patients with Acute Myeloid Leukemia. Curr Oncol. 2022;29:5198\u2013208.","journal-title":"Curr Oncol"},{"key":"1416_CR13","unstructured":"\u201cHer dying wish.\u201d Ontario parents want speedier stem cell transplants after daughter\u2019s death. CBC Radio [Internet]. 2016 May [cited 2024 Dec 13]; Available from: https:\/\/www.cbc.ca\/radio\/asithappens\/as-it-happens-thursday-edition-1.3568451\/her-dying-wish-ontario-parents-want-speedier-stem-cell-transplants-after-daughter-s-death-1.3568464."},{"key":"1416_CR14","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.jtct.2022.09.015","volume":"28","author":"LW Mau","year":"2022","unstructured":"Mau LW, Preussler JM, Meyer CL, Senneka MK, Wallerstedt S, Steinert P, et al. Trends in Allogeneic Hematopoietic Cell Transplantation Utilization and Estimated Unmet Need Among Medicare Beneficiaries with Acute Myelogenous Leukemia. Transplant Cell Ther. 2022;28:852\u20138.","journal-title":"Transplant Cell Ther"},{"key":"1416_CR15","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/s41409-018-0164-y","volume":"53","author":"VR Bhatt","year":"2018","unstructured":"Bhatt VR, Chen B, Gyawali B, Lee SJ. Socioeconomic and health system factors associated with lower utilization of hematopoietic cell transplantation in older patients with acute myeloid leukemia. Bone Marrow Transpl. 2018;53:1288\u201394.","journal-title":"Bone Marrow Transpl"},{"key":"1416_CR16","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1182\/bloodadvances.2023009765","volume":"7","author":"A Bashey","year":"2023","unstructured":"Bashey A, Zhang X, Morris LE, Holland HK, Bachier-Rodriguez L, Solomon SR, et al. Improved access to HCT with reduced racial disparities through integration with leukemia care and haploidentical donors. Blood Adv. 2023;7:3816\u201323.","journal-title":"Blood Adv"},{"key":"1416_CR17","doi-asserted-by":"publisher","first-page":"5051","DOI":"10.1182\/blood-2024-204122","volume":"144","author":"JM Preussler","year":"2024","unstructured":"Preussler JM, Meyer CL, Burns M. To Treat or Not to Treat: Factors Associated with Receipt of Allogeneic Hematopoietic Cell Transplant. Blood. 2024;144:5051.","journal-title":"Blood"},{"key":"1416_CR18","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1182\/blood-2017-03-772368","volume":"130","author":"L Muffly","year":"2017","unstructured":"Muffly L, Pasquini MC, Martens M, Brazauskas R, Zhu X, Adekola K, et al. Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States. Blood. 2017;130:1156\u201364.","journal-title":"Blood"}],"updated-by":[{"DOI":"10.1038\/s41408-026-01454-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000}}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41408-025-01416-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-025-01416-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-025-01416-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T06:32:46Z","timestamp":1772519566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41408-025-01416-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,23]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1416"],"URL":"https:\/\/doi.org\/10.1038\/s41408-025-01416-4","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,23]]},"assertion":[{"value":"18 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: In this article, the wrong version of Table 1 has been used. This has been corrected.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":9,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":10,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41408-026-01454-6","URL":"https:\/\/doi.org\/10.1038\/s41408-026-01454-6","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"TB received research funding from Imago Biosciences (a subsidiary of Merck) and honoraria from AVIR Pharma, Jazz Pharmaceuticals, Bristol Myers Squibb, and Riemser Pharma GmbH, as well as travel funding from Incyte, Abbvie, Astellas, Alexion, and Celgene. There are no other relevant disclosures for this study for the remaining authors of this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"204"}}